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Structured Abstract  
Background: It is estimated that 15% of children in the United States have at least one developmental delay, 
sadly, less than one-fifth of these children receive early intervention services before the age of three (Vitrikas, 
Savard, & Bucaj, 2017).  
Objectives: Design, implement, and evaluate an evidence-based protocol to assist in timely referrals of 
identified children to intervention services in a pediatric primary care setting through staff education of the 
developmental screening tool ASQ-3.  
Methods: Accurate assessment of current practice revealed the need for development and implementation of a 
protocol. Staff education was evaluated through pre and post-surveys. Data was collected pre and post-protocol 
implementation through chart reviews.  
Results: The post-protocol implementation data resulted in an increase in screening and 5 children being 
referred for early intervention services and 4 are being watched with areas of concern.  
Conclusions: Through education and the development of a protocol this quality improvement project improved 
quality of care, referrals, workflow, reimbursement, understanding, and overall developmental screening in this 
primary care practice.  
Implications: This developmental screening protocol will provide a foundation to increase overall screening in 
the practice. 
Keywords: “development”, “developmental screening”, “early intervention”, and “ASQ-3” 
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Introduction  
 Early identification of developmental delay is crucial for a child’s well-being (American Academy of 
Pediatrics [AAP], Council on Children with Disabilities, Section on Developmental Behavioral Pediatrics, 
Bright Futures Steering Committee, & Medical Home Initiatives for Children With Special Needs, 2006).  
Developmental delay can have a variety of origins; some children are born with risk factors that can predispose 
them to developmental delay, medical conditions can attribute to developmental delay, or children can show 
signs of delayed development in early childhood (AAP et al., 2006). It is estimated that 15% of children in the 
United States have at least one developmental delay, sadly, less than one-fifth of these children receive early 
intervention services before the age of three (Vitrikas et al., 2017). Early identification of a developmental 
concern allows the care team to further evaluate, diagnose, and treat the concerns before they are long-term 
problems (AAP et al., 2006). The American Academy of Pediatrics (AAP) et al. (2006) report that 
developmental surveillance is to be incorporated at every well-child visit and if any concerns are raised during 
surveillance then a standardized developmental screening test may be performed. However, parental concern 
and surveillance alone are often insufficient in identifying developmental delay (Vitrikas et al., 2017).  
Developmental screening is an inexpensive tool to complete a comprehensive assessment and 
objectively identify a child’s development (Berry, Garzon, & Deloian, 2013). Developmental screening tools 
assess for normal development using the five developmental domains; gross motor, fine motor, language, 
cognitive, and social skills (Scharf, Scharf, & Stroustrup, 2016). Effective implementation of developmental 
screening tools provides a consistent, reliable, and efficient method for screening for developmental delays 
while increasing parent satisfaction and allowing the provider-parent partnership in the care of their child to 
grow (Berry et al., 2013). Developmental screening is not intended to be diagnostic but rather to identify red 
flags that require further evaluation (Scharf et al., 2016). The AAP, in collaboration with Council on Children 
with Disabilities, Section on Developmental Behavioral Pediatrics, Bright Futures Steering Committee and 
Medical Home Initiatives for Children With Special Needs Project Advisory Committee developed an 
algorithm to guide primary care providers in developmental surveillance and screening in 2006 (AAP et al., 
4 
 
2006). The algorithm development reflected a recommendation that developmental surveillance is completed at 
every well-child visit and that developmental screening with a valid screening tool occurs at 9, 18, and 24 or 30-
month visits (AAP et al., 2006). AAP et al. (2006) state that there is no universally accepted screening tool that 
is appropriate for all populations and ages. Broad screening tools that address developmental domains that are 
culturally and linguistically sensitive as well as both reliable and valid with good sensitivity and specificity 
should be selected.  
Developmental screening tools that produce sensitivity and specificity levels of 70-80% (as cited in 
Barnes, 1982), are deemed acceptable for developmental screening. The Ages and Stages Questionnaire, third 
edition (ASQ-3) addresses the five developmental domains and an area to address general parental concerns 
(U.S. Department of Health and Human Services, 2014). The test-retest reliability of the ASQ-3 is 0.91 and 
inter-rater reliability is 0.92 (Ages & Stages Questionnaires [ASQ], 2017). The validity of the ASQ-3 is 
excellent at 0.82 to 0.88 with a sensitivity of 86% and specificity of 85% overall agreement (ASQ, 2017). A 
study compared the sensitivity and specificity of the ASQ and the Parents’ Evaluation of Developmental Status 
(PEDS) in preschool children and concluded that the ASQ had moderate sensitivity (82%) and specificity (78%) 
and the PEDS had moderate sensitivity (74%) but low specificity (64%) in screening for developmental delay 
(Limbos & Joyce, 2011). The ASQ has been effectively implemented in busy health care settings and found to 
be a reasonable and feasible method to complete developmental screening (King et al., 2010). San Antonio, 
Fenick, Shabanova, Leventhal, and Weitzman (2014) compared the validity and reliability of administration of 
the ASQ in the waiting rooms of busy pediatric offices to standardized conditions and concluded that there was 
no statistical difference in the fail percentage between the waiting room and standardized conditions (San 
Antonio et al., 2014). 
 Primary care providers respond well to education about screening tools and an educational intervention 
involving the whole practice system to increase the performance of routine screenings (Allen, Berry, Brewster, 
Chalasani, & Mack, 2010). As primary care offices become patient-centered medical homes, screening and 
referrals will improve and bridge the gap in evidence-based screening and outcomes (Mackridges & Ryherd, 
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2011). Overall, to properly utilize the ASQ-3 and incorporate it into a patient-centered medical home, the ASQ-
3 should be offered at regular intervals to allow for adequate screening and identification of children that 
require further intervention. For proper implementation of the ASQ-3 in a primary care setting a whole office 
quality-improvement approach is recommended.  
An independent, pediatric primary care office identified a problem with consistent use of the ASQ-3 in 
areas of screening at appropriate intervals, assessment of the screening results, real-time discussion with 
parents, and timely referral to appropriate organizations. For this practice, developmental screening occurred at 
9 and 15 months and results of the ASQ-3 were not being reviewed with the parents the day of the visit. The 
purpose of this quality improvement project was to implement an evidence-based practice protocol for the use 
of the ASQ-3 in a primary care setting to ensure that developmental screening occurred based on the AAP 
recommendations to allow for accurate assessment of the results, same day review of results with the parents, 
and timely referral to appropriate organizations. The objective of this quality improvement project was to 
design, implement, and evaluate the evidence-based office protocol.  
To appropriately address workflow inconsistencies of the ASQ-3 a clinical question was created: Does 
the implementation of an evidence-based office protocol outlining developmental screening at appropriate 
intervals using the ASQ-3, allow for accurate assessment of the screening results, real-time discussion with 
parents, and timely referral to appropriate organizations as well as improve office workflow, reimbursement, 
understanding, and overall developmental screening in this primary care practice? The Health Promotion Model 
(as cited in Pender, 1996) was used to develop concepts in relation to the use of developmental screening tools 
in primary care. The Kotter Change Model’s eight concepts guided the implementation of the evidence-based 
practice protocol to improve developmental screening in a primary care practice (Kotter International, 2017). 
Methods 
 This quality improvement project was designed to improve office workflow to increase overall 
developmental screening in the practice. The project took place at a mid-Michigan pediatric primary care 
practice that consists of two providers, one office manager, two financial/billing personnel, three medical 
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assistants as well as three administrative assistants. Implementation and evaluation of the intervention took 
place after current practice was assessed, old workflow was removed, and protocol was created.  
Intervention At onset of the project old workflow was removed and the protocol outlining new staff 
responsibilities and workflow was put into place. The protocol reflects the AAP recommended ages for 
screening as well as the ASQ-3 specific age window of when each tool should be administered based on the 
month that is being screened. This is reflected in the ASQ-3 scheduling guide (Table 1). This guide was placed 
at the front desk to assist with scheduling of well-child visits within the appropriate windows and for preparing 
charts. Each 9, 18, and 24-month well-child visit chart within the age range was flagged with a colored sheet to 
remind staff to distribute the ASQ-3 at this visit. Two copies of the 9, 18, and 24-month ASQ-3 and an 
educational sheet were printed on cardstock, laminated, and placed on book rings for easy parent handling. An 
education sheet was provided to assist parents in understanding the ASQ-3, the importance of developmental 
screening, and to decrease questions to administrative assistants. The education sheets were provided in the 
form of a flyer at the 6-month well-child visit as well as laminated and attached to the ASQ-3. The electronic 
health record (EHR) was updated with a check box and dialog box for providers to document the ASQ-3. The 
checkbox allowed providers to state that the ASQ-3 was complete and the dialog box allowed providers to 
select normal development, areas of concern, or referral needed. 
The protocol outlined the new office workflow and staff responsibilities. The workflow reflected that the 
administrative assistants distribute the appropriate laminated ASQ-3 and education sheet to the parent as they 
check in for their well-child visit. Once the ASQ-3 is complete, it is scored by the medical assistant. Once 
scored, the medical assistant notifies the provider that it is ready for review. The provider enters the room to 
complete the well visit and review the results of the ASQ-3 with the parents. Then the provider documents that 
the ASQ-3 was complete and their interpretation of the results in the designated fields in the EHR. Finally, the 
provider indicates the appropriate billing code 96110. The 96110 billing code accounts for developmental 
testing; limited (AAP et al., 2006). 
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Approach At the onset of the project, pre-implementation data was collected based on chart review to provide a 
baseline of children being screened using the ASQ-3 at 9, 18, and 24 month visits. A week prior to 
implementation, pre-implementation surveys were given to assess overall staff understanding of the ASQ-3, and 
the implementation protocol was presented to all staff that attended the staff meeting. Staff that were unable to 
attend were educated on the protocol one-on-one. Implementation of the protocol occurred in week one and 
weekly chart reviews were performed to assess progress of protocol implementation using a spreadsheet in 
week one through five. Final chart review for data collection and completion of the spreadsheet occurred in 
week six. The results of the data collected were reviewed with staff that attended a staff meeting in week seven. 
At this meeting, an assessment of staff perception and overall comments on protocol implementation occurred 
as well as the completion of the post-assessment surveys to assess staff education on ASQ-3. No additional 
education occurred during the post-assessment survey. 
Measures Data from pediatric patient charts that were seen for well-child visits at 9, 18, and 24 months, were 
reviewed pre and post-implementation. The pre-implementation data was collected to review pediatric patients 
seen at the 9, 18, and 24-month visits who were provided the ASQ-3 developmental screening tool for one 
month prior to process change. The post-implementation data included data from pediatric patients seen at the 9, 
18, and 24-month visits and provided the ASQ-3 developmental screening tool one month after process change. 
Data was also collected in pre and post-implementation surveys to address staff education.  
Analysis The charts of patients from 9, 18, and 24-month well-child visits were reviewed to obtain data 
regarding the child’s age, which well-child visit they were attending, if the ASQ-3 was completed (yes/no), if 
referral was needed (yes/no), if documented in the EHR (yes/no), and if billed using 96110 (yes/no). The 
quantitative data was recorded on a spreadsheet to examine pre and post-implementation differences. Pre and 
post-implementation survey data was collected on objective educational material such as developmental 
categories of the ASQ-3, valid age range for screening a 9 month old child, the AAP evidence-based ages for 
developmental screening, point value of a “yes” answer in scoring the ASQ-3, and appropriate billing code used 
to charge for the ASQ-3.  
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Ethical Considerations Data collection began after this project was deemed quality improvement by the 
Institutional Review Board (IRB). All data collected for this project was stored on an office computer at the 
pediatric primary care location, protected under a secured firewall, and not stored, shared, or saved on a thumb 
drive, or in cloud storage. 
Results  
The results of this project were analyzed based on the clinical question and focused on appropriate 
screening, referral rates, and staff education. Results for pre-implementation data focus on a chart review of one 
month (21 days of service) during which a total of 40 patients were seen in the practice for a 9, 18, or 24-month 
well-child visit. Results for post-implementation data focus on a chart review of one month (24 days of service) 
during which a total of 64 patients were seen in the practice for 9, 18, and 24-month well-child visit. Results of 
pre-implementation survey data included seven staff assessed immediately after attending a staff meeting and 
education. Results of post-implementation survey data included 10 staff assessed before the start of a staff 
meeting with no additional education.  
Appropriate Screening Rates 
 Appropriate screening rates were defined as the patients that were correctly screened using the ASQ-3 
based on the protocol; to be included, screening occurred within the proper age window, results of screening 
were documented in the EHR, and screening was billed correctly. Screening within the proper age window 
allows for accurate assessment results of the child’s development at that time. Reviewing documentation allows 
to objectively evaluate real-time discussion with parents. Providers documented the results after discussing the 
results with parents. Appropriate billing allows for proper reimbursement for the organization. 
 Pre-implementation screening rates at 9 months, seven of 14 patients (50%) were appropriately 
screened. At 18 months zero of 13 patients (0%) were appropriately screened and at 24 months zero of 13 
patients (0%) were appropriately screened. Overall, a total of seven of 40 patients (18%) were screened 
appropriately pre-implementation. 
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Post-implementation screening rates indicated that a total of nine of 22 (41%) patients were screened 
appropriately at the 9-month visit, a total of 12 of 22 (55%) patients were screened appropriately at the 18-
month visit, and a total of 11 of 20 (55%) patients were screened appropriately at the 24-month visit (Figure 1). 
Overall, a total of 32 of 64 patients (50%) were screened appropriately post-implementation compared to 18% 
pre-implementation resulting in a 32% increase in screening rates. 
Referral Rates 
 Pre-implementation referral data indicated that of the seven patients screened at 9 months, zero (0%) 
were referred to intervention services for developmental delay. There was no evidence in the chart review that a 
referral to intervention services was appropriate. Post-implementation referral data indicated that of the nine 
patients appropriately screened at the 9-month visit, three (33%) were referred for intervention services; one 
was referred for speech delay, and two for gross motor delay. Post-implementation referral data also indicated 
that of the 12 appropriately screened at the 18-month visit, two (17%) were referred for intervention services; 
one for speech delay, and one for gross motor delay. Lastly, the post-implementation referral data indicated that 
zero (0%) patients of the 11 patients appropriately screened at the 24-month well-visit required a referral for 
intervention services (Figure 2). Overall, five of 64 patients (8%) were referred to intervention services during 
the post implementation phase.  
Staff Education  
Staff education was evaluated through pre and post-surveys that were conducted at staff meetings pre 
and post-protocol implementation. Pre-implementation survey data found that of the seven staff two (29%) 
could correctly identify four of the five developmental categories that the ASQ-3 screens, four of seven (57%) 
could accurately identify the age range in which a 9-month screening tool must be administered, four of seven 
(57%) could identify when evidence-based developmental screening should occur, four of seven (57%) could 
identify the value of a “yes” answer in scoring the ASQ-3, and six of seven (85%) could accurately identify the 
correct billing code.  
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Post-implementation survey data found that of the 10 staff three (30%) could correctly identify four of 
the five developmental categories that the ASQ-3 screens, six of 10 (60%) could accurately identify the age 
range in which a 9-month screening tool must be administered, five of 10 (50%) could identify when evidence-
based developmental screening should occur, four of 10 (40%) could identify the value of a “yes” answer in 
scoring the ASQ-3, and two of ten (20%) could accurately identify the correct billing code (Figure 3). 
Surprisingly, staff education did not improve with protocol implementation. Although this was not a positive 
finding, it is evident that staff education did not affect the overall screening and referral rates in this 
organization. 
Discussion  
The purpose of this quality improvement project was to implement an evidence-based practice protocol 
for the use of the ASQ-3 in a primary care setting that outlines the appropriate ages for developmental screening 
based on AAP recommendations and improves workflow through education to office staff on their 
responsibilities, the ASQ-3 developmental screening tool overall, the referral process, and billing requirements. 
Utilizing the AAP recommendations for developmental screening increased the overall developmental 
screening in this pediatric primary care practice and a total of five children were referred to appropriate 
intervention services. Of these five children, two would not have been identified without the protocol 
implementation and workflow change to increase developmental screening at 18 and 24 months. 
All participants for this study were screened using their chronological age at the time of the well-child 
visit. The protocol did not reflect that the child’s age or office well-child visit be adjusted for prematurity in this 
study. Developmental screening is increasingly important for premature infants and careful consideration 
should be given to correctly adjusting the child’s age for prematurity in future studies. Adjusting the age for 
prematurity allows for an accurate assessment of the child’s development at that time while reducing the risk of 
over referral (D’Agostino et al., 2011). On further review of the study results, it was found that of the five 
children referred, one was born at 36 weeks’ gestation. Although age was not adjusted for this participant and a 
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referral was needed, it is important to note that developmental screening is not meant to be diagnostic but to be 
used in addition to the provider’s assessment of the child.   
While implementation data focuses on appropriate screening rates it should also be noted that the 
protocol improved overall staff compliance in screening by 37%. The improvement was demonstrated by a 
decrease in missed screening of children within the appropriate age window from 58% to 11% overall. While 
there was also an increase in correctly identifying children that should not be screened from 20 to 25% overall, 
close attention should be given to ensuring that children outside the age window are not screened since the non-
compliant screening of these children stayed relatively the same (5% pre-implementation, 6% post-
implementation). Overall screening improved 32% with only an 8% increase in errors in documentation and 
billing (Table 2 and Table 3). 
 Enhanced EHR documentation allowed four children to be appropriately identified as having 
developmental areas of concern needing continued surveillance. Based on low ASQ-3 scores in personal social 
skills, speech, and gross motor. However, the study did identify a 17% decrease in overall staff education, it is 
pertinent that ongoing staff education occur.  
Limitations Limitations to this quality improvement project are the small sample size and short implementation 
window. Another limitation was the inability to measure the real-time discussion with parents.  
Conclusion 
Developmental screening with evidence-based tools such as the ASQ-3, has proven to be an inexpensive 
method to complete a comprehensive assessment and objectively identify a child’s development. This quality 
improvement project including the development of a protocol to improve quality of care, referrals, workflow, 
reimbursement, and overall developmental screening in a pediatric primary care practice in mid-Michigan was 
successful. Improving office workflow to reflect evidence-based recommendations for developmental screening 
increased the number of children screened in this practice and allowed for timely referrals to early intervention 
services.  
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Implications for Practice and Further Study in the Field 
The implementation of this evidence-based protocol outlining developmental screening at appropriate 
intervals using the ASQ-3 in this primary care practice did have positive implications. This protocol 
implementation allowed for increased developmental screening being performed in the primary care practice 
and allowed for timely referrals to early intervention services. This protocol will provide a template for future 
protocols to increase overall screening in this primary care practice in a variety of topics and ages. 
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Figure 1. Screening Rates 
 
 Figure 2. Referrals 
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Figure 3. Staff Education  
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Tables 
 
Table 1. ASQ-3 Scheduling Guide 
Well-Visit Appropriate Dates for Screening 
9 Months 9 months 0 days – 9 months 30 days 
18 Months 17 month 0 days – 18 months 30 days 
24 Months 23 month 0 days – 25 month 15 days 
 
Table 2. Compliance with Protocol Pre-Implementation  
*Numbers may not add to 100% due to rounding 
 
Table 3. Compliance with Protocol Post- Implementation 
 
 Compliant  Not Compliant 
 Appropriately 
Screened 
(Within Age 
Range/ 
Results 
Documented/ 
Billed) 
Appropriately 
Not Screened 
(Outside Age 
Range) 
 Outside Age 
Range/Results 
Documented/ 
Billed) 
Within Age 
Range/Not 
Screened 
Within Age 
Range/Results 
Documented/Not 
Billed 
Within Age 
Range/Results Not 
Documented/Billed 
9 Months 7/14 (50%) 1/14 (7%)  2/14 (14%) 4/14 (29%) 0/14 (0%) 0/14 (0%) 
18 Months 0/13 (0%) 6/13 (46%)  0/13 (0%) 7/13 (54%) 0/13 (0%) 0/13 (0%) 
24 Months 0/13 (0%) 1/13 (8%)  0/13 (0%) 12/13 (92%) 0/13 (0%) 0/13 (0%) 
Total 7/40 (18%) 8/40 (20%)  2/40 (5%) 23/40 (58%) 0/40 (0%) 0/40 (0%) 
Overall  38% Compliant*  63% Not Compliant* 
 Compliant  Not Compliant 
 Appropriately 
Screened (Within 
Age Range/ 
Results 
Documented/ 
Billed) 
Appropriately Not 
Screened (Outside 
Age Range) 
 Outside Age 
Range/Results 
Documented/ Billed) 
Within Age 
Range/Not 
Screened 
Within Age 
Range/Results 
Documented/Not 
Billed 
Within Age 
Range/Results Not 
Documented/Billed 
9 Months 9/22 (41%) 6/22 (27%)  2/22 (9%) 2/22 (9%) 1/22 (5%) 2/22 (9%) 
18 Months 12/22 (55%) 5/22 (23%)  2/22 (9%) 2/22 (9%) 1/22 (5%) 0/22 (0%) 
24 Months 11/20 (55%) 5/20 (25%)  0/20 (0%) 3/20 (15%) 0/20 (0%) 1/20 (5%) 
Total 32/64 (50%) 16/64 (25%)  4/64 (6%) 7/64 (11%) 2/64 (3%) 3/64 (5%) 
Overall  75% Compliant  25% Not Compliant 
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Objectives for Presentation
1. Discuss the importance of developmental 
screening
2. Current literature about ASQ-3 
3. Discuss the design, implementation, and 
evaluation of an evidence-based office protocol 
to improve office workflow and overall 
developmental screening in a primary care 
setting. 
The Problem
• Children with developmental delays are not being 
identified early enough to fully benefit from early 
intervention programs (Rice et al., 2014).
• It is estimated that 15% of children in the United 
States have at least one developmental delay, 
sadly, less than one-fifth of these children receive 
early intervention services before the age of three 
(Vitrikas et al., 2017). 
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Introduction
• Developmental delay 
– Variety of origins (AAP et al., 2006). 
• Early identification allows for further 
evaluation, diagnosis, and treatment of the 
concerns before they are long-term problems (AAP 
et al., 2006). 
• Developmental surveillance 
– Parental concern and surveillance alone are often 
insufficient in identifying developmental delay (Vitrikas et 
al., 2017). 
Background
• Developmental screening is an inexpensive method to 
complete a comprehensive assessment and objectively 
identify a child’s development (Berry et al., 2013). 
• Developmental screening tools assess for normal 
development using the five developmental domains (Scharf, Scharf, & 
Stroustrup, 2016).
• Effective implementation of developmental screening tools 
provides a consistent, reliable, and efficient method for 
screening for developmental delays while increasing parent 
satisfaction and allowing the provider-parent partnership in 
the care of their child to grow (Berry et al., 2013).
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Developmental Screening
• The American Academy of Pediatrics (AAP), in 
collaboration with Council on Children with 
Disabilities, Section on Developmental 
Behavioral Pediatrics, Bright Futures Steering 
Committee and Medical Home Initiatives for 
Children With Special Needs Project Advisory 
Committee developed an algorithm to guide 
primary care providers in developmental 
surveillance and screening in 2006 (AAP et al., 2006). 
• Developmental screening is not intended to be 
diagnostic but to identify red flags that require 
further evaluation (Scharf et al., 2016). 
• No universally accepted screening tool that is 
appropriate for all populations and ages (AAP et al., 2006) 
– Tools that produce sensitivity and specificity 
levels of 70-80% are deemed acceptable for 
developmental screening (Barnes, 1982; AAP et al., 2006). 
(AAP et al., 2006) 
Ages and Stages Questionnaire (ASQ-3)
• Parent-completed questionnaire
• Addresses all developmental domains
• Test-retest reliability of 0.91 and inter-rater reliability of 0.92 
(USDHHS, 2014; Ages & Stages Questionnaires [ASQ], 2017). 
• Validity is excellent at 0.82 to 0.88 (ASQ, 2017). 
• Sensitivity of 86% and specificity of 85% overall agreement (ASQ, 
2017). 
• Culturally and linguistically sensitive 
– Arabic, English, French, Spanish or Vietnamese (ASQ, 2017).
• 10-15 minutes for parents to complete (ASQ, 2016).
• 2-3 minutes for professionals to score (ASQ, 2016).
4/26/18
5
Canadian Foundation for Healthcare Improvement’s (CFHI) Assessment Tool 
Organizational Assessment Tool 
(Canadian Foundation for Healthcare Improvement, 2014)
Assessment of Organization
• Inconsistencies 
– Screening
• 9 and 15 months
– Assessment of the screening results
– Real-time discussion with parents
– Timely referral 
• Documentation
• Billing
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SWOT Analysis
Internal External
Strengths Opportunities
• Currently using ASQ-3 
• Staff have been educated 
• Large population of children 9 mo-2 
years
• Parents willing to participate
• Desire to provide high quality patient 
care
• Appropriately billing
• Improve the quality patient care
• Increased revenue through billing
• Provider/parent relationship
• Systemic quality improvement
Weaknesses Threats
• Many inconsistencies with delivery, 
reviewing, and retrieval process
• Not reflecting AAP recommendations
• Not all children being assessed due to 
large population 
• Missing opportunities for full re-
imbursement
• Length of well-child visit
• Parents dissatisfaction 
• Parents finding new practice/provider
• Results of ASQ-3 not being fully 
evaluated or explained to parents
• Parents having to follow-up  
Literature Review Findings
• Sensitivity and Specificity
– ASQ had moderate sensitivity (82%) and specificity (78%) (Limbos & Joyce, 2011). 
• Reliability and Validity
– ASQ test-retest reliability had a 95% confidence interval for all five domains 
– No statistically significance in the reliability of the ASQ under each condition 
– The ASQ is an effective developmental screening tool for identifying risk for 
developmental delay in a real-world setting (San Antonio et al., 2014).
• Use of ASQ-3 in Primary Care
– Effectively implemented in busy health care settings (King et al., 2010). 
– Primary care providers respond well to education and interventions involving 
the whole practice system to increase the performance of routine screenings (Allen, 
Berry, Brewster, Chalasani, & Mack, 2010).  
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Clinical Question
• Does the implementation of an evidence-based office protocol 
outlining developmental screening at appropriate intervals 
using the ASQ-3, allow for accurate assessment of the 
screening results, real-time discussion with parents, and timely 
referral to appropriate organizations as well as improve office 
workflow, reimbursement, understanding, and overall 
developmental screening in this primary care practice? 
Project Plan
• Purpose
– To implement a developmental screening protocol for the use of the ASQ-3
• Type
– Quality improvement
• Setting
– Mid-Michigan pediatric primary care practice 
• Resources
– Staff time
– Computer use
– Printed, laminated, and bought materials
• Participants
– All children attending a 9, 18, and 24 month well-child visit. 
– Providers, office manager, financial/billing personnel, medical assistants, and 
administrative assistants.
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IRB Approval
• Approval was granted from Grand 
Valley State University’s Human 
Research Review Committee’s 
(HRCC) Institutional Review Board 
(IRB) and deemed a quality 
improvement project.
• All data collected for this project was 
• Protected under a secured firewall 
on office computers
• Not stored, shared, or saved on a 
thumb drive, or in cloud storage. 
Kotter’s Change Model
Implementation Model
(Kotter International, 2017) 
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Theoretical Framework
Health Promotion Model
(McEwen, 2014) 
Project Objectives
• Design an evidence-based office protocol to 
improve office workflow and overall 
developmental screening 
• Remove old workflow
• Implement protocol
• Evaluate protocol  
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Phases of Project Implementation
1. Obtained pre-protocol data to provide a 
baseline
2. Developed an office protocol and educational 
sheets
3. Presented the protocol and educational sheets 
for stakeholder review
4. Conducted pre-assessment surveys during a 
staff meeting prior to protocol 
implementation
5. Removed old workflow 
6. Implemented the new office protocol 
reflecting new workflow
7. Obtained weekly chart reviews 
assessing progress of implementation 
in week 1-5 
8. Displayed weekly progress reports for 
organization
9. Conducted post-assessment surveys 
and presented a final data review to the 
stakeholders during a staff meeting in 
week 6 
10. Disseminating the results
Protocol
• Age
• Education
– Provided at 6 month visit
– During screening
• Job Responsibilities 
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Preparing for Implementation
ASQ-3 Scheduling Guide 
Well-Visit Appropriate Dates for Screening
9 Months 9 months 0 days – 9 months 30 days
18 Months 17 month 0 days – 18 months 30 days
24 Months 23 month 0 days – 25 month 15 days
• Screening within the proper age window allows for an accurate assessment 
of the child’s development at that time
Preparing for Implementation
• ASQ-3
– Two sets of the 9, 18, and 24-month were copied on cardstock 
and laminated. 
• One on book rings and one on a clipboard
• Education 
– Flyer 
– Education sheet 
• Laminated 
• Attached with ASQ-3
• EHR updated 
– Check box
– Dialog box
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Implementing New Workflow
1. The ASQ-3 and educational sheet were given 
to the parents on a laminated sheet upon 
arrival, by the administrative assistant, and 
completed with a dry erase marker in the 
waiting room and/or patient room. 
2. After being completed, the tool was scored by 
the medical assistant. 
3. Once scored, the medical assistant notified 
the provider that it is ready for review. 
4. The provider entered the room and complete 
the well-child exam, reviewed the results of 
the ASQ-3 with the parents, documented, and 
billed. 
Methods
• Data from pediatric patient charts that were 
seen for well-child visits at 9, 18, and 24 
months
– Pre and post-implementation
– One month prior to and after process change 
• Data was also collected in pre and post-
implementation surveys to address staff 
education.
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Measures
• The charts were reviewed to 
obtain data pre and post-
implementation data regarding 
• Child’s age
• Well-child exam
• ASQ-3 completed (yes/no)
• Referred (yes/no)
• Documented (yes/no) 
• Billed (yes/no)
• Pre and post-implementation 
survey data was collected on 
objective educational material 
• Developmental categories the 
ASQ-3 screens
• Valid age range for screening a 9-
month old child
• The AAP evidence-based ages for 
developmental screening
• Point value of a “yes” answer in 
scoring the ASQ-3
• Appropriate billing code used to 
charge for the ASQ-3
Analysis and Results
• Results of this project were analyzed based on the 
clinical question and focused on appropriate screening 
rates, referral rates, and staff education. 
– Pre-implementation data 
• One month (21 days of service) 
– 40 patients
– Post-implementation data 
• One month (24 days of service) 
– 64 patients
– Pre-Survey
• 7 of 11 staff completed
– Post-Survey
• 10 of 11 staff completed
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Results
Appropriate Screening Rates
• The patients that were correctly screened using 
the ASQ-3 based on the protocol 
– Proper age window
– Results were documented
– Billed correctly
Screening Rates
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Compliance with Protocol 
Pre-Implementation
Compliant Not Compliant
Appropriately 
Screened (Within 
Age Range/ 
Results 
Documented/ 
Billed)
Appropriately Not 
Screened (Outside 
Age Range)
Outside Age 
Range/Results 
Documented/ 
Billed)
Within Age 
Range/Not 
Screened
Within Age 
Range/Results 
Documented/Not 
Billed
Within Age 
Range/Results Not 
Documented/Billed
9 Months 7/14 (50%) 1/14 (7%) 2/14 (14%) 4/14 (29%) 0/14 (0%) 0/14 (0%)
18 Months 0/13 (0%) 6/13 (46%) 0/13 (0%) 7/13 (54%) 0/13 (0%) 0/13 (0%)
24 Months 0/13 (0%) 1/13 (8%) 0/13 (0%) 12/13 (92%) 0/13 (0%) 0/13 (0%)
Total 7/40 (18%) 8/40 (20%) 2/40 (5%) 23/40 (58%) 0/40 (0%) 0/40 (0%)
Overall 38% Compliant* 63% Not Compliant*
*Numbers may not add to 100% due to rounding
Compliance with Protocol 
Post-Implementation
Compliant Not Compliant
Appropriately Screened 
(Within Age Range/ 
Results Documented/ 
Billed)
Appropriately Not 
Screened (Outside Age 
Range)
Outside Age Range/Results 
Documented/ Billed)
Within Age 
Range/Not 
Screened
Within Age 
Range/Results 
Documented/Not Billed
Within Age Range/Results 
Not Documented/Billed
9 Months 9/22 (41%) 6/22 (27%) 2/22 (9%) 2/22 (9%) 1/22 (5%) 2/22 (9%)
18 Months 12/22 (55%) 5/22 (23%) 2/22 (9%) 2/22 (9%) 1/22 (5%) 0/22 (0%)
24 Months 11/20 (55%) 5/20 (25%) 0/20 (0%) 3/20 (15%) 0/20 (0%) 1/20 (5%)
Total 32/64 (50%) 16/64 (25%) 4/64 (6%) 7/64 (11%) 2/64 (3%) 3/64 (5%)
Overall 75% Compliant 25% Not Compliant
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Referral Rates
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Discussion
• It can be determined that utilizing the AAP 
recommendations for developmental screening 
increased the overall developmental screening in this 
pediatric primary care practice and a total of five 
children were able to be referred to appropriate 
intervention services.
• Of the five children referred, two would not have been 
identified without the protocol implementation and 
workflow change to increase developmental screening 
at 18 and 24 months.
Discussion 
• Enhanced EHR documentation allowed four 
children to be identified as having 
developmental areas of concern needing 
continued surveillance.
• Encouraged real-time discussion with parents.
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Limitations
• Small sample size and short implementation 
window
• Not having an objective measure for real-time 
discussion with parents. 
• 17% decrease in overall staff education, it is 
pertinent that ongoing staff education occur. 
Implications for Practice
• Developmental screening being performed in the 
primary care practice increased and allowed for 
timely referrals to early intervention services. 
• This protocol will provide a template for future 
protocols to increase overall screening in this 
primary care practice in a variety of topics and 
ages.
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Conclusions
• The development of this protocol improved quality of 
care, referrals, workflow, reimbursement, and overall 
developmental screening in this pediatric primary care 
practice. 
• Improving office workflow to reflect evidence-based 
recommendations for developmental screening 
increased the number of children screened in this 
practice and allowed for five children to have timely 
referrals to early intervention services. 
Budget/Resources
Personnel or Item Hourly Wage X Projected 
Time
Cost of Item
Pediatrician $276.00
Physician Assistant $129.00
Medical Assistant $48.00
Office Manager $108.00
Administrative Assistant $45.00
DNP Student (In kind 
donation)
$6,144.00
Computer $500.00
Educational 
Documents/Supplies
$40.00
Lamination $100.00
Dry Erase Markers $15.00
Total Expenses $606.00 $655.00
Total Revenue $6,144.00
Net $5,538.00
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Sustainability
• The protocol will have the ability to be adapted 
to other recommended screening for children, 
adolescents and young adults such as an 
adolescent risk screening tool (Hagen, Shaw, & Duncan, 2013). 
– Bright Futures recommended screening
• The organization has a new NP that has 
expressed interest in sustaining this project.
Dissemination
• Presented results to the organization
• Presenting my final defense to my advisory team
• Poster will be presented at Michigan NAPNAPs 
spring conference
• Final paper is written in manuscript form for 
preparation for publication
• Submitting final manuscript to Scholarworks
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Reflection on DNP Essentials
• Essential I: Scientific Unpinnings for Practice
– Used nursing and change theories to guide my quality improvement 
project.
– Preformed a thorough literature review
• Essential II: Organizational and Systems Leadership for 
Quality Improvement and Systems Thinking
– Positively impacted the practice policies and procedures to meet the 
healthcare needs of the patient population and created and sustained 
changes at the organizational level.  
• Essential III: Clinical Scholarship and Analytical 
Methods for Evidence-Based Practice
– Used analytic methods to conduct a comprehensive literature review to 
determine and implement the best evidence for practice. 
(American Association of College of Nursing [AACN], 2006)
Reflection on DNP Essentials
• Essential IV: Information Systems/Technology and Patient 
Care Technology for the Improvement and Transformation of 
Health Care
– Improved quality of care through enhancing EHR documentation and 
adequately evaluating the EHR documentation.
• Essential V: Health Care Policy for Advocacy in Health Care
– Advocated for the nursing profession within the practice.
– Project advocates for evidence-based practice for the vulnerable 
population
• Essential VI: Interprofessional Collaboration for Improving 
Patient and Population 
– Effectively communicated and collaborated with the practice team in 
development, implementation, and evaluation of the quality 
improvement project.  
(AACN, 2006)
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Reflection on DNP Essentials
• Essential VII: Clinical Prevention and Population Health for 
Improving the Nation’s Health
– Implementation of this quality improvement project increased referrals 
for developmental delay and will continue to provide a protocol 
focused on clinical prevention and aim to increase the overall health for 
this population. 
• Essential VIII: Advanced Nursing Practice
– Demonstrated advanced clinical judgment, systems thinking, and 
accountability through designing, implementing, and evaluating the 
evidence-based practice protocol for developmental screening.
(AACN, 2006)
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